Prognostic significance of biomarkers in predicting outcome in patients with coronary artery disease and left ventricular dysfunction: results of the biomarker substudy of the Surgical Treatment for Ischemic Heart Failure trials - Wikidata - awgldk - TriplyDB

Prognostic significance of biomarkers in predicting outcome in patients with coronary artery disease and left ventricular dysfunction: results of the biomarker substudy of the Surgical Treatment for Ischemic Heart Failure trials

Prognostic significance of biomarkers in predicting outcome in patients with coronary artery disease and left ventricular dysfunction: results of the biomarker substudy of the Surgical Treatment for Ischemic Heart Failure trials

http://www.wikidata.org/entity/Q30413291

about

BAG3: a new player in the heart failure paradigm The five-point Likert scale for dyspnea can properly assess the degree of pulmonary congestion and predict adverse events in heart failure outpatients Circulating levels of tumor necrosis factor-alpha receptor 2 are increased in heart failure with preserved ejection fraction relative to heart failure with reduced ejection fraction: evidence for a divergence in pathophysiology Level of perioperative B-type natriuretic peptide associates with heart function after on-pump coronary artery bypass graft surgery on a beating heart.Time-Course of the Effects of QSYQ in Promoting Heart Function in Ameroid Constrictor-Induced Myocardial Ischemia Pigs.The ixCELL-DCM Trial: Rationale and Design.10-Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients With Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease) T

P2860

Q28088321-ED860F4C-4C07-4FC4-B72C-5B558C244FE6 Q33574810-3DA42266-13D2-4F29-B85E-606D5BAF1786 Q33748856-B50FD347-1C4C-4B95-8AEC-F30CBEA4D92D Q35765942-8AEAE069-8F04-4224-9DA4-062865DC2930 Q37730618-CCC1B7A1-B45B-46F2-97C0-1C1DD6D07088 Q47791214-7A0AEF0C-0DA7-4CBE-A111-A1FFDC22A4CD Q55445795-3AEC6F4D-A8B6-4569-9B86-BBC80D730564

P2860

Prognostic significance of biomarkers in predicting outcome in patients with coronary artery disease and left ventricular dysfunction: results of the biomarker substudy of the Surgical Treatment for Ischemic Heart Failure trials

http://www.wikidata.org/entity/Q30413291

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Prognostic significance of bio ...... Ischemic Heart Failure trials

@ast

Prognostic significance of bio ...... Ischemic Heart Failure trials

@en

type

label

Prognostic significance of bio ...... Ischemic Heart Failure trials

@ast

Prognostic significance of bio ...... Ischemic Heart Failure trials

@en

prefLabel

Prognostic significance of bio ...... Ischemic Heart Failure trials

@ast

Prognostic significance of bio ...... Ischemic Heart Failure trials

@en

P1433

Q30413291-84A20AAD-4B24-4667-AE12-26993C7E290F

P1476

Q30413291-3FD0AB67-C554-43C6-A5AE-4C3FCB62258C

P2093

Q30413291-03861579-BE33-45CD-B30B-CAE57A48B12E

Q30413291-087753FC-CCBC-4F5B-BA56-6C8E3BEADDEC

Q30413291-0D2C9F7B-E1D8-4FCD-B641-B05276B07664

Q30413291-1E8E32B5-39B8-4E34-A0F2-492649262085

Q30413291-25642753-42F7-4A15-B898-E67CFA8236E8

Q30413291-33375A22-339A-4BC5-A631-33B24A612325

Q30413291-365FB698-DCAB-4B5A-9AF3-12CEF5B88213

Q30413291-4CED34F9-D924-49AB-B5E6-2AD7BB0A4E96

Q30413291-4F287DED-A4B8-4F09-A0DF-9C3190931498

Q30413291-5FD3680C-6049-4FFE-8AD4-F57C30B1F593

P2860

Q30413291-00B09EA8-EFAF-4A49-B839-E0701701FABD

Q30413291-0A984FF3-3542-4B0B-82CD-ED435AC07059

Q30413291-0F38EE9D-9A7F-4B71-899A-6FF06DA1EFE2

Q30413291-1EC02632-372F-4D65-997F-38C93923ED77

Q30413291-22CA8B52-A9A9-49C5-86A9-8BDADBACAD5B

Q30413291-2D36FA7C-03B8-4BF1-B67A-AE401C7451A4

Q30413291-3AADF979-36A8-4DB7-90EF-A55C0C9FE3C9

Q30413291-535A469F-D4E7-43E6-BB6D-CD89E6977D6D

Q30413291-537C3753-B2B7-46D1-A625-59D0F5965308

Q30413291-63A02290-443A-496B-8DE3-E100D234BE5C

P304

Q30413291-7AB53D5A-A890-46A3-955E-C32977DF2CA7

P31

Q30413291-92D36074-F704-4C38-890E-53AF0B5CADC8

P356

Q30413291-D12D5DCB-7407-4648-836D-E748D6C7DF1A

P433

Q30413291-6EEDB573-14AE-4F91-9CF8-87926C4BC782

P478

Q30413291-A2123BEF-EDFB-43EA-97E7-893E23E7D916

P50

Q30413291-7D094DBD-A494-4FE6-B6F2-9DC497EBD5FF

Q30413291-D3868E46-25BB-4B6A-90EE-03F0CE62A82B

P577

Q30413291-90C91C78-F606-4943-B05E-B0DD8E2F4F38

P698

Q30413291-3BB35C65-BC90-4B70-82F9-B2B79A65FA67

P921

Q30413291-864C7022-384D-4ABF-9EFC-83E59FB7F77B

Q30413291-FDC6087C-CB46-4C5C-B721-6CE0BC26A8A9

P932

Q30413291-D5117EBC-B255-41C8-8D6B-B62EF93C5247

P356

CIRCHEARTFAILURE.112.000185

P1433

Circulation: Heart Failure

P1476

Prognostic significance of bio ...... Ischemic Heart Failure trials

@en

P2093

Alan S Maisel

http://www.w3.org/2001/XMLSchema#string

Arthur M Feldman

http://www.w3.org/2001/XMLSchema#string

Carla A Sueta

http://www.w3.org/2001/XMLSchema#string

Daniel F Pauly

http://www.w3.org/2001/XMLSchema#string

Dennis M McNamara

http://www.w3.org/2001/XMLSchema#string

Dorellyn L Lee

http://www.w3.org/2001/XMLSchema#string

Eric J Velazquez

http://www.w3.org/2001/XMLSchema#string

Gretchen Wells

http://www.w3.org/2001/XMLSchema#string

Irene Lang

http://www.w3.org/2001/XMLSchema#string

John F Schmedtje

http://www.w3.org/2001/XMLSchema#string

P2860

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims.

The role of tumor necrosis factor alpha in the pathophysiology of congestive heart failure.

Evaluating the yield of medical tests.

Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery.

The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial.

Coronary bypass surgery with or without surgical ventricular reconstruction

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.

P304

461-472

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCHEARTFAILURE.112.000185

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Douglas L. Mann

P577

2013-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23584092

http://www.w3.org/2001/XMLSchema#string

P921

cardiac surgery

P932

3905743

http://www.w3.org/2001/XMLSchema#string